Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mycopene
- Development stage
- Unknown
- Lead developer
- Grevis Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Mycopene is an oral nutritional supplement developed by Grevis Pharma. It is formulated as a softgel capsule containing a combination of antioxidants, carotenoids, vitamins, and minerals, including lycopene, lutein, mixed carotenes, beta-carotene, zinc, selenium, and copper. Mycopene is primarily used to support eye health, reduce oxidative stress, and address nutritional deficiencies. The carotenoids lutein and beta-carotene help protect eye cells from light damage and lower the risk of age-related macular degeneration and cataracts, while lycopene, zinc, selenium, and copper provide robust systemic antioxidant protection.
- Brand names
- Mycopene
Beyond the preview
Go deeper on Mycopene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mycopene.